Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2001
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors
G Griebel, G Perrault, J Simiand, et al.
Minerva Pediatrica
|
May 20, 2014
Association between mode of delivery and neonatal deaths and complications in term pregnancy: a cohort study in Brazil
L C Machado Júnior, C E Sevrin, E Oliveira, et al.
Cancer Medicine
|
November 29, 2024
Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee
François Sevrin, Emilie Bogart, Daniel Orbach, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair
Badia Ferzaz, Emmanuel Brault, Genevieve Bourliaud, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 7, 2003
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile
Yves Claustre, Danielle De Peretti, Philippe Brun, et al.
Pediatric Blood & Cancer
|
August 14, 2023
Phase II study of <sup>131</sup> I-metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP
François Sevrin, Hélène Kolesnikov-Gauthier, Olivier Cougnenc, et al.
Cadernos De Saude Publica
|
January 31, 2009
[Association between mode of delivery and maternal complications in a public hospital in Greater Metropolitan São Paulo, Brazil]
Luís Carlos Machado Junior, Christian Eric Sevrin, Emerson de Oliveira, et al.
Signal Transduction and Targeted Therapy
|
April 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia
Fanny Gonzales, Pauline Peyrouze, Djohana Laurent, et al.
Pharmacology, Biochemistry, and Behavior
|
July 16, 2008
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia
Denis Boulay, Philippe Pichat, Gihad Dargazanli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 16, 2005
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic
Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2001
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors
G Griebel, G Perrault, J Simiand, et al.
Minerva Pediatrica
|
May 20, 2014
Association between mode of delivery and neonatal deaths and complications in term pregnancy: a cohort study in Brazil
L C Machado Júnior, C E Sevrin, E Oliveira, et al.
Cancer Medicine
|
November 29, 2024
Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee
François Sevrin, Emilie Bogart, Daniel Orbach, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair
Badia Ferzaz, Emmanuel Brault, Genevieve Bourliaud, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 7, 2003
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile
Yves Claustre, Danielle De Peretti, Philippe Brun, et al.
Pediatric Blood & Cancer
|
August 14, 2023
Phase II study of <sup>131</sup> I-metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP
François Sevrin, Hélène Kolesnikov-Gauthier, Olivier Cougnenc, et al.
Cadernos De Saude Publica
|
January 31, 2009
[Association between mode of delivery and maternal complications in a public hospital in Greater Metropolitan São Paulo, Brazil]
Luís Carlos Machado Junior, Christian Eric Sevrin, Emerson de Oliveira, et al.
Signal Transduction and Targeted Therapy
|
April 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia
Fanny Gonzales, Pauline Peyrouze, Djohana Laurent, et al.
Pharmacology, Biochemistry, and Behavior
|
July 16, 2008
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia
Denis Boulay, Philippe Pichat, Gihad Dargazanli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 16, 2005
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic
Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, et al.
Page
of 12